Literature DB >> 29240526

Wells syndrome secondary to influenza vaccination: A case report and review of the literature.

Tyler Safran1, Marina Masckauchan2, Jakub Maj2, Lawrence Green2.   

Abstract

Vaccinations have been shown repeatedly to be extremely safe with low incidence of complications. Given the rarity, these adverse events, they must be reported and examined cautiously. This case report illustrates the first case of an adult presenting with Wells syndrome that developed soon after vaccination with the thiomersal, a common preservative, containing influenza vaccine. Wells syndrome, also known as eosinophilic cellulitis, is an uncommon dermatologic condition of unknown etiology. Lesions in patients with Wells syndrome (eosinophilic cellulitis) progress over a few days to become large indurated plaques with associated edema and erythema. Although the etiology of Wells syndrome remains unknown, certain precipitants have been described in the literature, including but not limited to parasitic infections, contact dermatitis, Churg-Strauss disease and various medications. This article describes a possible sensitivity to thiomersal, as well as describes other cases that have reported a similar sensitivity secondary to receiving thiomersal-containing vaccines.

Entities:  

Keywords:  Eosinophilic cellulitis; Influenza; Vaccination; Wells Syndrome

Mesh:

Substances:

Year:  2018        PMID: 29240526      PMCID: PMC5893209          DOI: 10.1080/21645515.2017.1417714

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  7 in total

1.  Wells' syndrome following thiomersal-containing vaccinations.

Authors:  Karen J Koh; Lachlan Warren; Lynette Moore; Craig James; Geoffrey N Thompson
Journal:  Australas J Dermatol       Date:  2003-08       Impact factor: 2.875

2.  Relapse of Wells' syndrome in a child after tetanus-diphtheria immunization.

Authors:  Jacob Calvert; Andrew R Shors; Robin L Hornung; Solmaz P Poorsattar; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2006-05       Impact factor: 11.527

Review 3.  [Vaccine safety].

Authors:  K Weisser; I Barth; B Keller-Stanislawski
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2009-11       Impact factor: 1.513

4.  Wells' syndrome related to tetanus vaccine.

Authors:  M Moreno; J Luelmo; M Monteagudo; R Bella; A Casanovas
Journal:  Int J Dermatol       Date:  1997-07       Impact factor: 2.736

5.  Wells syndrome in adults and children: a report of 19 cases.

Authors:  Ruggero Caputo; Angelo V Marzano; Pamela Vezzoli; Luisa Lunardon
Journal:  Arch Dermatol       Date:  2006-09

6.  Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant.

Authors:  Kara Heelan; John F Ryan; Neil H Shear; Conleth A Egan
Journal:  J Dermatol Case Rep       Date:  2013-12-30

7.  Diagnosis and management of eosinophilic cellulitis (Wells' syndrome): A case series and literature review.

Authors:  Hani Sinno; Jean-Philip Lacroix; James Lee; Ali Izadpanah; Ronnie Borsuk; Kevin Watters; Mirko Gilardino
Journal:  Can J Plast Surg       Date:  2012
  7 in total
  1 in total

1.  Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination.

Authors:  E Cinotti; J-L Perrot; F Bruzziches; L Tognetti; A Batsikosta; E Sorrentino; A V Marzano; P Rubegni
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-11-20       Impact factor: 9.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.